The Breadth of Cross Sub-Type Neutralisation Activity of a Single Domain Antibody to Influenza Hemagglutinin Can Be Increased by Antibody Valency

Simon E. Hufton(University of Hertfordshire), Stephen Poole(National Institute for Biological Standards and Control), Paul Risley(National Institute for Biological Standards and Control), Othmar G. Engelhardt(National Institute for Biological Standards and Control), Diane Major(National Institute for Biological Standards and Control), Christina R. Ball(National Institute for Biological Standards and Control)
PLoS ONE
August 1, 2014
10.1371/journal.pone.0103294
Cited by 44

Related Papers

Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system
|Vaccine|2004|156
Reproducibility of Serologic Assays for Influenza Virus A (H5N1)
|Emerging infectious diseases|2009|150
A sensitive retroviral pseudotype assay for influenza H5N1‐neutralizing antibodies
|Influenza and Other Respiratory Viruses|2007|148
A phase I clinical trial of a PER.C6® cell grown influenza H7 virus vaccine
|Vaccine|2009|140
The development of vaccine viruses against pandemic A(H1N1) influenza
|Vaccine|2011|109